GSK plc Reports Total Voting Rights as of Sept 30, 2024
Ticker: GLAXF · Form: 6-K · Filed: Oct 1, 2024 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Oct 1, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-capital, voting-rights, disclosure
TL;DR
GSK's share count is stable at 3.01B shares as of Sept 30, 2024. No changes.
AI Summary
GSK plc announced its total voting rights and capital as of September 30, 2024. The company's issued share capital remains unchanged, with a total of 3,010,660,704 ordinary shares of 31.25 pence each in issue. This notification is in accordance with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R.
Why It Matters
This filing provides transparency on the company's share capital, which is crucial for investors to understand their voting power and potential dilution.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of share capital and voting rights, with no new financial or operational information that would indicate increased risk.
Key Numbers
- 3,010,660,704 — Issued Ordinary Shares (Total number of shares as of September 30, 2024.)
Key Players & Entities
- GSK plc (company) — Registrant
- 3,010,660,704 (dollar_amount) — Total issued ordinary shares
- 30 September 2024 (date) — Reporting date for share capital
- Financial Conduct Authority (company) — Regulator
FAQ
What is the total number of issued ordinary shares of GSK plc as of September 30, 2024?
As of September 30, 2024, GSK plc had 3,010,660,704 ordinary shares of 31.25 pence each in issue.
What is the nominal value of each ordinary share?
Each ordinary share has a nominal value of 31.25 pence.
What rule requires GSK plc to make this notification?
GSK plc is making this notification in conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R.
Has GSK plc's issued share capital changed recently?
This filing indicates the total voting rights and capital as of September 30, 2024, and implies no change from previous reporting periods as no new shares are mentioned as being issued.
What is the company's principal executive office address?
The company's principal executive office is located at 79 New Oxford Street, London, WC1A 1DG.
Filing Stats: 321 words · 1 min read · ~1 pages · Grade level 11.8 · Accepted 2024-10-01 11:12:03
Filing Documents
- a5121g.htm (6-K) — 16KB
- 0001654954-24-012564.txt ( ) — 17KB
SIGNATURES
SIGNATURES     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.   GSK plc   (Registrant)     Date: October 01, 2024         By:/s/ VICTORIA WHYTE --------------------------       Victoria Whyte   Authorised Signatory for and on   behalf of GSK plc